A press release reports that the Michael C Greiner, executive vice president and chief financial officer (CFO), of AngioDynamics will be departing the company. It adds that Stephen A Trowbridge—senior vice president and general counsel—will assume the role of interim Chief Financial Officer in addition to his current responsibilities.
Greiner will remain with AngioDynamics to facilitate a smooth transition of duties up to the filing of the second fiscal quarter 10-Q, and the company has initiated a process to determine a permanent successor. According to a press release, Greiner’s departure is unrelated to AngioDynamics’ business performance, financial reporting, or controls. The company is reaffirming its previously issued financial guidance for fiscal year 2020.
Jim Clemmer, president and chief executive officer of AngioDynamics, says: “We have made meaningful progress since Michael joined AngioDynamics three years ago. We are a stronger company today, and Michael has played an integral role in the transformation of our portfolio, strengthening of our balance sheet and building a talented and capable finance and accounting team. Completing the acquisition of Eximo Medical was a significant milestone that offered us an opportunity to reflect on the accomplishments of the past three years and evaluate our future. Michael and I mutually agreed that now is the right time to bring a new perspective to the organization as we enter our next phase of execution. On behalf of the Board of Directors and everyone at AngioDynamics, I want to thank Michael for all of his contributions, and we wish him and his family all the best.”